Hypotension Treatment: Early Vasopressor Therapy

We are studying whether starting vasopressor therapy early helps hypotensive patients in the emergency department recover faster than standard fluid therapy. This may reduce the need for intensive care admission.

>2 yearsConfirmation phase (III)No PlaceboStandard MedicinesInjectionCardiologyInfectious DiseasesInternal MedicinePulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Noradrenaline Hydrochloride
Noradrenaline hydrochloride is a substance that raises blood pressure by narrowing blood vessels and supporting heart function in severe low blood pressure or shock.
Norepinephrine
Norepinephrine is a substance that raises blood pressure by tightening blood vessels and supporting heart pumping during severe low-blood-pressure emergencies.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Aarhus Universitet
Emergency Department
Århus, Denmark
Bispebjerg Hospital
The Emergency Department
Copenhagen, Denmark
Sydvestjysk Sygehus
Department of Emergency Medicine
Esbjerg, Denmark

Sponsor: Odense University Hospital
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.